$AGIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGIOS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AGIOS PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 51.09 | 500 | 25,545 | 89,737 | 90.2 K to 89.7 K (-0.55 %) |
Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 51.09 | 500 | 25,545 | 89,697 | 90.2 K to 89.7 K (-0.55 %) |
Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 50.64 | 500 | 25,320 | 90,237 | 90.7 K to 90.2 K (-0.55 %) |
Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 50.64 | 500 | 25,320 | 90,197 | 90.7 K to 90.2 K (-0.55 %) |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 1,900 | 575 | 189,656 | |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 1,100 | 333 | 191,556 | |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 50.02 | 1,900 | 95,038 | 0 | 1.9 K to 0 (-100.00 %) |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 1,900 | 575 | 1,900 | 0 to 1.9 K |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 50.02 | 1,100 | 55,022 | 0 | 1.1 K to 0 (-100.00 %) |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 1,100 | 333 | 1,100 | 0 to 1.1 K |
May 31 2017 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 48.20 | 16,000 | 771,200 | 16,000 | |
May 25 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 46.92 | 509 | 23,882 | 90,737 | 91.2 K to 90.7 K (-0.56 %) |
May 25 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 46.92 | 509 | 23,882 | 90,697 | 91.2 K to 90.7 K (-0.56 %) |
May 25 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 47.27 | 509 | 24,060 | 91,246 | 91.8 K to 91.2 K (-0.55 %) |
May 25 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 47.27 | 509 | 24,060 | 91,206 | 91.7 K to 91.2 K (-0.55 %) |
May 02 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 192,656 | |
May 02 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 50.06 | 3,000 | 150,180 | 0 | 3 K to 0 (-100.00 %) |
May 02 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |
Apr 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | P | 49.50 | 624,575 | 30,916,463 | 1,856,353 | 1.2 M to 1.9 M (+50.71 %) |
Apr 19 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 50.92 | 509 | 25,918 | 91,755 | 92.3 K to 91.8 K (-0.55 %) |
Apr 19 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 50.92 | 509 | 25,918 | 91,715 | 92.2 K to 91.7 K (-0.55 %) |
Apr 19 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 55.27 | 1,527 | 84,397 | 92,264 | 93.8 K to 92.3 K (-1.63 %) |
Apr 19 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 55.27 | 1,527 | 84,397 | 92,224 | 93.8 K to 92.2 K (-1.63 %) |
Apr 19 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 55.13 | 509 | 28,061 | 93,791 | 94.3 K to 93.8 K (-0.54 %) |
Apr 19 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 55.13 | 509 | 28,061 | 93,751 | 94.3 K to 93.8 K (-0.54 %) |
Apr 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 195,656 | |
Apr 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 58.62 | 3,000 | 175,860 | 0 | 3 K to 0 (-100.00 %) |
Apr 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |
Mar 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 53.91 | 509 | 27,440 | 94,300 | 94.8 K to 94.3 K (-0.54 %) |
Mar 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 53.91 | 509 | 27,440 | 94,260 | 94.8 K to 94.3 K (-0.54 %) |
Mar 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 52.31 | 509 | 26,626 | 94,809 | 95.3 K to 94.8 K (-0.53 %) |
Mar 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 52.31 | 509 | 26,626 | 94,769 | 95.3 K to 94.8 K (-0.53 %) |
Mar 22 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 5,933 | 53,694 | 48,157 | |
Mar 22 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 505 | 236 | 4,969 | |
Mar 22 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.00 | 505 | 27,775 | 15,470 | 16 K to 15.5 K (-3.16 %) |
Mar 22 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 505 | 236 | 15,975 | 15.5 K to 16 K (+3.26 %) |
Mar 22 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.00 | 5,933 | 326,315 | 15,470 | 21.4 K to 15.5 K (-27.72 %) |
Mar 22 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 5,933 | 53,694 | 21,403 | 15.5 K to 21.4 K (+38.35 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.43 | 40 | 1,977 | 0 | 40 to 0 (-100.00 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 52.15 | 400 | 20,859 | 40 | 440 to 40 (-90.91 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 51.34 | 8,734 | 448,376 | 440 | 9.2 K to 440 (-95.20 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.69 | 31,425 | 1,592,996 | 9,174 | 40.6 K to 9.2 K (-77.40 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.18 | 20,237 | 1,015,416 | 40,599 | 60.8 K to 40.6 K (-33.26 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.47 | 27,622 | 1,366,400 | 60,836 | 88.5 K to 60.8 K (-31.23 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.28 | 57,488 | 2,890,439 | 88,458 | 145.9 K to 88.5 K (-39.39 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.13 | 83,750 | 4,114,813 | 145,946 | 229.7 K to 145.9 K (-36.46 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 48.36 | 53,985 | 2,610,828 | 229,696 | 283.7 K to 229.7 K (-19.03 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 36,152 | 0 | 109,230 | 73.1 K to 109.2 K (+49.47 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 25,412 | 0 | 73,078 | 47.7 K to 73.1 K (+53.31 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 48.75 | 8,400 | 409,482 | 283,681 | 292.1 K to 283.7 K (-2.88 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 47.73 | 42,596 | 2,032,979 | 292,081 | 334.7 K to 292.1 K (-12.73 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.35 | 1,000 | 50,346 | 334,677 | 335.7 K to 334.7 K (-0.30 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.90 | 46,938 | 2,342,408 | 335,677 | 382.6 K to 335.7 K (-12.27 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.56 | 34,650 | 1,751,821 | 382,615 | 417.3 K to 382.6 K (-8.30 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 54.17 | 1,780 | 96,428 | 417,265 | 419 K to 417.3 K (-0.42 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 50.40 | 142,900 | 7,202,160 | 142,900 | |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
Feb 17 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 201,656 | |
Feb 17 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 50.01 | 6,000 | 300,060 | 0 | 6 K to 0 (-100.00 %) |
Feb 17 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
Jan 27 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 9.05 | 68,182 | 617,047 | 136,363 | |
Jan 27 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 9.05 | 34,090 | 308,515 | 54,090 | |
Jan 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 41.73 | 16,000 | 667,680 | 16,000 | |
Dec 22 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Gift | G | 0.00 | 7,800 | 0 | 40,470 | 48.3 K to 40.5 K (-16.16 %) |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 6,520 | 206,293 | 35,286 | |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 14,091 | 127,524 | 20,000 | |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 6,889 | 3,221 | 5,474 | |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 27,500 | 1,787,500 | 48,270 | 75.8 K to 48.3 K (-36.29 %) |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 6,520 | 206,293 | 75,770 | 69.3 K to 75.8 K (+9.42 %) |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 14,091 | 127,524 | 69,250 | 55.2 K to 69.3 K (+25.55 %) |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 6,889 | 3,221 | 55,159 | 48.3 K to 55.2 K (+14.27 %) |
Nov 16 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 5,000 | 325,000 | 6,000 | 11 K to 6 K (-45.45 %) |
Nov 14 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.00 | 2,128 | 127,680 | 11,000 | 13.1 K to 11 K (-16.21 %) |
Nov 14 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.00 | 2,872 | 172,320 | 13,128 | 16 K to 13.1 K (-17.95 %) |
Nov 09 2016 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 52.29 | 15,000 | 784,350 | 15,000 | |
Oct 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 48.97 | 625 | 30,606 | 107,818 | 108.4 K to 107.8 K (-0.58 %) |
Oct 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 48.97 | 627 | 30,704 | 107,778 | 108.4 K to 107.8 K (-0.58 %) |
Oct 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 48.91 | 625 | 30,569 | 108,443 | 109.1 K to 108.4 K (-0.57 %) |
Oct 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 48.91 | 627 | 30,667 | 108,405 | 109 K to 108.4 K (-0.58 %) |
Oct 06 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 55.00 | 5,000 | 275,000 | 16,000 | 21 K to 16 K (-23.81 %) |
Sep 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 54.00 | 625 | 33,750 | 109,068 | 109.7 K to 109.1 K (-0.57 %) |
Sep 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 54.00 | 627 | 33,858 | 109,032 | 109.7 K to 109 K (-0.57 %) |
Sep 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 54.15 | 625 | 33,844 | 109,693 | 110.3 K to 109.7 K (-0.57 %) |
Sep 28 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 54.15 | 627 | 33,952 | 109,659 | 110.3 K to 109.7 K (-0.57 %) |
Sep 22 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 50.00 | 5,000 | 250,000 | 21,000 | 26 K to 21 K (-19.23 %) |
Sep 21 2016 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 49.83 | 125,000 | 6,228,750 | 125,000 | |
Aug 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 36.81 | 625 | 23,006 | 110,318 | 110.9 K to 110.3 K (-0.56 %) |
Aug 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 36.81 | 627 | 23,080 | 110,286 | 110.9 K to 110.3 K (-0.57 %) |
Aug 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 37.81 | 625 | 23,631 | 110,943 | 111.6 K to 110.9 K (-0.56 %) |
Aug 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 37.81 | 627 | 23,707 | 110,913 | 111.5 K to 110.9 K (-0.56 %) |
Aug 11 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Buy | J | 0.00 | 917 | 0 | 2,778 | 1.9 K to 2.8 K (+49.27 %) |
Jul 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 43.74 | 625 | 27,338 | 111,568 | 112.2 K to 111.6 K (-0.56 %) |
Jul 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 43.74 | 627 | 27,425 | 111,540 | 112.2 K to 111.5 K (-0.56 %) |
Jul 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 41.85 | 625 | 26,156 | 112,193 | 112.8 K to 112.2 K (-0.55 %) |
Jul 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 41.85 | 627 | 26,240 | 112,167 | 112.8 K to 112.2 K (-0.56 %) |
Jun 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 43.38 | 625 | 27,113 | 125,318 | 125.9 K to 125.3 K (-0.50 %) |
Jun 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 43.38 | 627 | 27,199 | 125,294 | 125.9 K to 125.3 K (-0.50 %) |
Jun 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 40.37 | 625 | 25,231 | 125,943 | 126.6 K to 125.9 K (-0.49 %) |
Jun 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 40.37 | 627 | 25,312 | 125,921 | 126.5 K to 125.9 K (-0.50 %) |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 31,125 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 47.33 | 8,500 | 402,305 | 48,875 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 41,125 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 29,250 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 47.33 | 9,000 | 425,970 | 45,899 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 31,125 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 47.33 | 9,000 | 425,970 | 58,400 | |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 176,579 | |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 15,200 | 7,106 | 285,991 | |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 5,194 | 164,338 | 301,191 | |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 22,306 | 10,428 | 306,385 | |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 15,200 | 7,106 | 74,270 | 59.1 K to 74.3 K (+25.73 %) |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 27,500 | 1,787,500 | 59,070 | 86.6 K to 59.1 K (-31.77 %) |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 5,194 | 164,338 | 86,570 | 81.4 K to 86.6 K (+6.38 %) |
Jun 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 22,306 | 10,428 | 81,376 | 59.1 K to 81.4 K (+37.76 %) |
May 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 52.88 | 625 | 33,050 | 126,568 | 127.2 K to 126.6 K (-0.49 %) |
May 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 52.88 | 627 | 33,156 | 126,548 | 127.2 K to 126.5 K (-0.49 %) |
May 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 50.50 | 625 | 31,563 | 127,193 | 127.8 K to 127.2 K (-0.49 %) |
May 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 50.50 | 627 | 31,664 | 127,175 | 127.8 K to 127.2 K (-0.49 %) |
Apr 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 51.88 | 625 | 32,425 | 127,818 | 128.4 K to 127.8 K (-0.49 %) |
Apr 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 51.88 | 627 | 32,529 | 127,802 | 128.4 K to 127.8 K (-0.49 %) |
Apr 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 55.00 | 625 | 34,375 | 128,443 | 129.1 K to 128.4 K (-0.48 %) |
Apr 27 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 55.00 | 627 | 34,485 | 128,429 | 129.1 K to 128.4 K (-0.49 %) |
Mar 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 38.09 | 625 | 23,806 | 129,068 | 129.7 K to 129.1 K (-0.48 %) |
Mar 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 38.09 | 627 | 23,882 | 129,056 | 129.7 K to 129.1 K (-0.48 %) |
Mar 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 36.28 | 625 | 22,675 | 129,693 | 130.3 K to 129.7 K (-0.48 %) |
Mar 31 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 36.28 | 627 | 22,748 | 129,683 | 130.3 K to 129.7 K (-0.48 %) |
Feb 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 38.89 | 625 | 24,306 | 130,465 | 131.1 K to 130.5 K (-0.48 %) |
Feb 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 38.89 | 627 | 24,384 | 130,459 | 131.1 K to 130.5 K (-0.48 %) |
Feb 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 36.90 | 625 | 23,063 | 131,090 | 131.7 K to 131.1 K (-0.47 %) |
Feb 29 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 36.90 | 627 | 23,136 | 131,086 | 131.7 K to 131.1 K (-0.48 %) |
Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 39.76 | 100,000 | 3,976,000 | 100,000 | |
Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 39.76 | 45,220 | 1,797,947 | 328,691 | |
Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 39.76 | 102,000 | 4,055,520 | 997,501 | |
Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 39.76 | 20,330 | 808,321 | 108,572 | |
Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 39.76 | 45,220 | 1,797,947 | 177,220 | |
Feb 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 10,000 | 4,675 | 283,471 | |
Feb 10 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 10,000 | 4,675 | 59,070 | 49.1 K to 59.1 K (+20.38 %) |
Feb 01 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 41.52 | 625 | 25,950 | 131,715 | 132.3 K to 131.7 K (-0.47 %) |
Feb 01 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 41.52 | 627 | 26,033 | 131,713 | 132.3 K to 131.7 K (-0.47 %) |
Feb 01 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 44.33 | 625 | 27,706 | 132,340 | 133 K to 132.3 K (-0.47 %) |
Feb 01 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 44.33 | 627 | 27,795 | 132,340 | 133 K to 132.3 K (-0.47 %) |
Jan 11 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 15,000 | 7,013 | 293,471 | |
Jan 11 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 15,000 | 7,013 | 49,070 | 34.1 K to 49.1 K (+44.03 %) |
Jan 11 2016 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 20,000 | 6,050 | 895,501 | |
Jan 11 2016 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 20,000 | 6,050 | 272,272 | 252.3 K to 272.3 K (+7.93 %) |
Jan 05 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 5,500 | 174,020 | 308,471 | |
Jan 05 2016 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.27 | 5,500 | 358,985 | 34,070 | 39.6 K to 34.1 K (-13.90 %) |